Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHIGATEC: Shigamabs in Children with STPB Infection
NCT01252199Phase 2Completed
- Sponsor
- Thallion Pharmaceuticals Inc.
- Start
- Nov 2010
- Primary completion
- Dec 2012
- Modality
- Monoclonal Antibodies
- Countries
- 3
01
Overview
A Phase 2 trial of Shigamabs in Shiga toxin-producing Escherichia coli infection (STEC), sponsored by Thallion Pharmaceuticals Inc.. Started Nov 2010; status: completed.
02
Drugs
Shigamabs
03
Conditions
Shiga toxin-producing Escherichia coli infection (STEC)
Beyond the preview
Go deeper on NCT01252199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01252199.